JESSICA ANGELL: Open Payments
NPI 1033407028 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,759 in 54 payments from 15 companies in 2025. Trend: 2023 $1,024 · 2024 $3,011 · 2025 $2,759
Food & beverage: $1,920Travel & lodging: $839
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. | 4 | $1,354 |
| Janssen Biotech, Inc. | 17 | $616 |
| ABBVIE INC. | 13 | $378 |
| GENZYME CORPORATION | 4 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| Ardelyx, Inc. | 2 | $40 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| QOL Medical, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
Products named: TREMFYA, RINVOQ, LINZESS, XIFAXAN, DUPIXENT, SKYRIZI, IBSRELA, IQIRVO.
Industry payments across OH — which companies pay providers there.
